United States Oncolytic Virus Market Report 2018

March 2018 | 114 pages | ID: UD5DA2F4076QEN
QYResearch

Abstracts

In this report, the United States Oncolytic Virus market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oncolytic Virus in these regions, from 2013 to 2025 (forecast).

United States Oncolytic Virus market competition by top manufacturers/players, with Oncolytic Virus sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Otsuka Pharmaceutical Co
• Pfizer
• Roche
• Cold Genesys
• Genelux
• Latima
• Neotropix
• Shanghai Sunway Biotech
• SillaJen
• Takara Bio
• Theravir

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• HSV-based Oncolytic Viruses
• Adenoviruses-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pharmaceutical
• Health Care
• Commerical

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Oncolytic Virus Market Report 2018

1 ONCOLYTIC VIRUS OVERVIEW

1.1 Product Overview and Scope of Oncolytic Virus
1.2 Classification of Oncolytic Virus by Product Category
  1.2.1 United States Oncolytic Virus Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Oncolytic Virus Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 HSV-based Oncolytic Viruses
  1.2.4 Adenoviruses-based Oncolytic Viruses
  1.2.5 Vaccinia Virus-based Oncolytic Viruses
  1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
  1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
1.3 United States Oncolytic Virus Market by Application/End Users
  1.3.1 United States Oncolytic Virus Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Pharmaceutical
  1.3.3 Health Care
  1.3.4 Commerical
1.4 United States Oncolytic Virus Market by Region
  1.4.1 United States Oncolytic Virus Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Oncolytic Virus Status and Prospect (2013-2025)
  1.4.3 Southwest Oncolytic Virus Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Oncolytic Virus Status and Prospect (2013-2025)
  1.4.5 New England Oncolytic Virus Status and Prospect (2013-2025)
  1.4.6 The South Oncolytic Virus Status and Prospect (2013-2025)
  1.4.7 The Midwest Oncolytic Virus Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Oncolytic Virus (2013-2025)
  1.5.1 United States Oncolytic Virus Sales and Growth Rate (2013-2025)
  1.5.2 United States Oncolytic Virus Revenue and Growth Rate (2013-2025)

2 UNITED STATES ONCOLYTIC VIRUS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oncolytic Virus Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Oncolytic Virus Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Oncolytic Virus Average Price by Players/Suppliers (2013-2018)
2.4 United States Oncolytic Virus Market Competitive Situation and Trends
  2.4.1 United States Oncolytic Virus Market Concentration Rate
  2.4.2 United States Oncolytic Virus Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oncolytic Virus Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ONCOLYTIC VIRUS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Oncolytic Virus Sales and Market Share by Region (2013-2018)
3.2 United States Oncolytic Virus Revenue and Market Share by Region (2013-2018)
3.3 United States Oncolytic Virus Price by Region (2013-2018)

4 UNITED STATES ONCOLYTIC VIRUS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Oncolytic Virus Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Oncolytic Virus Revenue and Market Share by Type (2013-2018)
4.3 United States Oncolytic Virus Price by Type (2013-2018)
4.4 United States Oncolytic Virus Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ONCOLYTIC VIRUS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Oncolytic Virus Sales and Market Share by Application (2013-2018)
5.2 United States Oncolytic Virus Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ONCOLYTIC VIRUS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oncolytic Virus Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Otsuka Pharmaceutical Co
  6.2.2 Oncolytic Virus Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Oncolytic Virus Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Oncolytic Virus Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Cold Genesys
  6.5.2 Oncolytic Virus Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Cold Genesys Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Genelux
  6.6.2 Oncolytic Virus Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Genelux Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Latima
  6.7.2 Oncolytic Virus Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Latima Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Neotropix
  6.8.2 Oncolytic Virus Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Neotropix Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Shanghai Sunway Biotech
  6.9.2 Oncolytic Virus Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 SillaJen
  6.10.2 Oncolytic Virus Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 SillaJen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Takara Bio
6.12 Theravir

7 ONCOLYTIC VIRUS MANUFACTURING COST ANALYSIS

7.1 Oncolytic Virus Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncolytic Virus

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oncolytic Virus Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncolytic Virus Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ONCOLYTIC VIRUS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Oncolytic Virus Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Oncolytic Virus Sales Volume Forecast by Type (2018-2025)
11.3 United States Oncolytic Virus Sales Volume Forecast by Application (2018-2025)
11.4 United States Oncolytic Virus Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oncolytic Virus
Figure United States Oncolytic Virus Market Size (K Units) by Type (2013-2025)
Figure United States Oncolytic Virus Sales Volume Market Share by Type (Product Category) in 2017
Figure HSV-based Oncolytic Viruses Product Picture
Figure Adenoviruses-based Oncolytic Viruses Product Picture
Figure Vaccinia Virus-based Oncolytic Viruses Product Picture
Figure Vesicular Stomatitis Virus-based Oncolytic Viruses Product Picture
Figure Newcastle Disease Virus-based Oncolytic Viruses Product Picture
Figure United States Oncolytic Virus Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Oncolytic Virus by Application in 2017
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Health Care Examples
Table Key Downstream Customer in Health Care
Figure Commerical Examples
Table Key Downstream Customer in Commerical
Figure United States Oncolytic Virus Market Size (Million USD) by Region (2013-2025)
Figure The West Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oncolytic Virus Sales (K Units) and Growth Rate (2013-2025)
Figure United States Oncolytic Virus Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oncolytic Virus Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Oncolytic Virus Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Oncolytic Virus Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oncolytic Virus Sales Share by Players/Suppliers
Figure 2017 United States Oncolytic Virus Sales Share by Players/Suppliers
Figure United States Oncolytic Virus Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Oncolytic Virus Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Oncolytic Virus Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oncolytic Virus Revenue Share by Players/Suppliers
Figure 2017 United States Oncolytic Virus Revenue Share by Players/Suppliers
Table United States Market Oncolytic Virus Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Oncolytic Virus Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Oncolytic Virus Market Share of Top 3 Players/Suppliers
Figure United States Oncolytic Virus Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oncolytic Virus Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oncolytic Virus Product Category
Table United States Oncolytic Virus Sales (K Units) by Region (2013-2018)
Table United States Oncolytic Virus Sales Share by Region (2013-2018)
Figure United States Oncolytic Virus Sales Share by Region (2013-2018)
Figure United States Oncolytic Virus Sales Market Share by Region in 2017
Table United States Oncolytic Virus Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Oncolytic Virus Revenue Share by Region (2013-2018)
Figure United States Oncolytic Virus Revenue Market Share by Region (2013-2018)
Figure United States Oncolytic Virus Revenue Market Share by Region in 2017
Table United States Oncolytic Virus Price (USD/Unit) by Region (2013-2018)
Table United States Oncolytic Virus Sales (K Units) by Type (2013-2018)
Table United States Oncolytic Virus Sales Share by Type (2013-2018)
Figure United States Oncolytic Virus Sales Share by Type (2013-2018)
Figure United States Oncolytic Virus Sales Market Share by Type in 2017
Table United States Oncolytic Virus Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Oncolytic Virus Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oncolytic Virus by Type (2013-2018)
Figure Revenue Market Share of Oncolytic Virus by Type in 2017
Table United States Oncolytic Virus Price (USD/Unit) by Types (2013-2018)
Figure United States Oncolytic Virus Sales Growth Rate by Type (2013-2018)
Table United States Oncolytic Virus Sales (K Units) by Application (2013-2018)
Table United States Oncolytic Virus Sales Market Share by Application (2013-2018)
Figure United States Oncolytic Virus Sales Market Share by Application (2013-2018)
Figure United States Oncolytic Virus Sales Market Share by Application in 2017
Table United States Oncolytic Virus Sales Growth Rate by Application (2013-2018)
Figure United States Oncolytic Virus Sales Growth Rate by Application (2013-2018)
Table Merck Basic Information List
Table Merck Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Merck Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Merck Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Otsuka Pharmaceutical Co Basic Information List
Table Otsuka Pharmaceutical Co Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Otsuka Pharmaceutical Co Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Otsuka Pharmaceutical Co Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Otsuka Pharmaceutical Co Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Pfizer Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Pfizer Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Roche Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Roche Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Cold Genesys Basic Information List
Table Cold Genesys Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cold Genesys Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Cold Genesys Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Cold Genesys Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Genelux Basic Information List
Table Genelux Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genelux Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Genelux Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Genelux Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Latima Basic Information List
Table Latima Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Latima Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Latima Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Latima Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Neotropix Basic Information List
Table Neotropix Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Neotropix Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Neotropix Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Neotropix Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Shanghai Sunway Biotech Basic Information List
Table Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai Sunway Biotech Oncolytic Virus Sales Growth Rate (2013-2018)
Figure Shanghai Sunway Biotech Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure Shanghai Sunway Biotech Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table SillaJen Basic Information List
Table SillaJen Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure SillaJen Oncolytic Virus Sales Growth Rate (2013-2018)
Figure SillaJen Oncolytic Virus Sales Market Share in United States (2013-2018)
Figure SillaJen Oncolytic Virus Revenue Market Share in United States (2013-2018)
Table Takara Bio Basic Information List
Table Theravir Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncolytic Virus
Figure Manufacturing Process Analysis of Oncolytic Virus
Figure Oncolytic Virus Industrial Chain Analysis
Table Raw Materials Sources of Oncolytic Virus Major Players/Suppliers in 2017
Table Major Buyers of Oncolytic Virus
Table Distributors/Traders List
Figure United States Oncolytic Virus Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Oncolytic Virus Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Oncolytic Virus Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Oncolytic Virus Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oncolytic Virus Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oncolytic Virus Sales Volume (K Units) Forecast by Type in 2025
Table United States Oncolytic Virus Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oncolytic Virus Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oncolytic Virus Sales Volume (K Units) Forecast by Application in 2025
Table United States Oncolytic Virus Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Oncolytic Virus Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oncolytic Virus Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oncolytic Virus Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources